Stephen C. Delaney, Jr.: Debarment Order, 61003-61004 [2012-24528]
Download as PDF
pmangrum on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices
31073, June 5, 2007. The changes are as
follows:
I. Under Chapter KA, Office of the
Assistant Secretary, delete KA.00
Mission in its entirety and replace with
the following:
KA.00 MISSION. The Office of the
Assistant Secretary for Children and
Families (OAS) provides executive
direction, leadership, and guidance for
all ACF programs. OAS provides
national leadership to develop and
coordinate public and private initiatives
for carrying out programs that promote
permanency placement planning, family
stability, and self-sufficiency. OAS
advises the Secretary on issues affecting
America’s children and families,
including Native Americans, refugees,
and legalized aliens. OAS provides
leadership on human service issues and
conducts emergency preparedness and
response operations during a nationally
declared emergency.
II. Under Chapter KN, Office of Public
Affairs, delete KN.00 Mission in its
entirety and replace with the following:
KN.00 MISSION. The Office of Public
Affairs (OPA) develops, directs and
coordinates public affairs and
communication services for ACF. It
provides leadership, direction and
oversight in promoting ACF’s public
affairs policies, programs and
initiatives. OPA handles Freedom of
Information Act requests and inquiries
and coordinates hotline calls received
by the Office of Inspector General and
the Government Accountability Office
relating to ACF operations and
personnel. The Office of Public Affairs
also provides printing and distribution
services for ACF.
III. Under Chapter KN, Office of
Public Affairs, delete KN.20 Paragraph B
in its entirety and replace with the
following:
B. Division of Public Information
develops and implements public affairs
strategies to achieve ACF program
objectives in coordination with other
ACF components. It coordinates news
media relations strategy; responds to all
media inquiries concerning ACF
programs and related issues; develops
fact sheets, news releases, feature
articles for magazines and other
publications on ACF programs and
initiatives; and manages preparation
and clearance of speeches and official
statements on ACF programs. It
coordinates regional public affairs
policies and public affairs activities
pertaining to ACF programs and
initiatives. The Office coordinates
hotline calls received by the Office of
Inspector General and the Government
Accountability Office relating to ACF
operations and personnel and assists the
VerDate Mar<15>2010
15:25 Oct 04, 2012
Jkt 229001
ACF FOIA Officer in processing FOIA
inquiries and requests relating to ACF
programs and activities.
Dated: September 21, 2012.
George H. Sheldon,
Acting Assistant Secretary for Children and
Families.
[FR Doc. 2012–24587 Filed 10–4–12; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0405]
Stephen C. Delaney, Jr.: Debarment
Order
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is issuing an
order under the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) debarring
Stephen C. Delaney, Jr. for a period of
5 years from importing articles of food
or offering such articles for importation
into the United States. FDA bases this
order on a finding that Mr. Delaney was
convicted of one felony count under
Federal law for conduct relating to the
importation into the United States of an
article of food. Mr. Delaney was given
notice of the proposed debarment and
an opportunity to request a hearing
within the timeframe prescribed by
regulation. As of August 10, 2012 (30
days after receipt of the notice), Mr.
Delaney had not responded. Mr.
Delaney’s failure to respond constitutes
a waiver of his right to a hearing
concerning this action.
DATES: This order is effective October 5,
2012.
ADDRESSES: Submit applications for
termination of debarment to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Kenny Shade, Office of Regulatory
Affairs, Food and Drug Administration,
12420 Parklawn Dr., Rockville, MD
20857, 301–796–4640.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Section 306(b)(1)(C) of the FD&C Act
(21 U.S.C. 335a(b)(1)(C)) permits FDA to
debar an individual from importing an
article of food or offering such an article
for import into the United States if FDA
finds, as required by section
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
61003
306(b)(3)(A) of the FD&C Act (21 U.S.C.
335a(b)(3)(A)), that the individual has
been convicted of a felony for conduct
relating to the importation into the
United States of any food.
On April 8, 2011, Mr. Delaney was
convicted in the U.S. District Court for
the District of Massachusetts of one
count of false labeling under the Lacey
Act in violation of 16 U.S.C. 3372(d).
FDA’s finding that debarment is
appropriate is based on the felony
conviction referenced herein for
conduct relating to the importation into
the United States of any food. The
factual basis for this conviction is as
follows: As alleged in the indictment
that was filed against Mr. Delaney, he
was the president and owner of a
seafood packing and re-packing
company. On or about April 15, 2009,
in violation of 16 U.S.C. 3372(d), he
knowingly made and submitted a false
record, account and label for, and a false
identification of fish that had been and
was intended to be, imported,
purchased, and received from a foreign
country and transported in interstate
commerce, and involved the sale and
purchase, the offer of sale and purchase,
and the intent to sell and purchase, fish
with a market value of approximately
$8,000. Specifically, Mr. Delaney falsely
labeled imported frozen fillets of
pollock, product of China, as cod loins,
product of Canada.
As a result of his conviction, on July
9, 2012, FDA sent Mr. Delaney a notice
by certified mail proposing to debar him
for a period of 5 years from importing
articles of food or offering such articles
for import into the United States. The
proposal was based on a finding under
section 306(b)(1)(C) of the FD&C Act
that Mr. Delaney was convicted of a
felony under Federal law for conduct
relating to the importation into the
United States of an article of food
because he knowingly made and
submitted a false record, account and
label for, and a false identification of
fish that had been and was intended to
be, imported, purchased, and received
from a foreign country and transported
in interstate commerce, and involved
the sale and purchase, the offer of sale
and purchase, and intent to sell and
purchase, fish with a market value of
approximately $8,000.
The proposal was also based on a
determination, after consideration of the
factors set forth in section 306(c)(3) of
the FD&C Act (21 U.S.C. 335a(c)(3)), that
Mr. Delaney should be subject to a 5year period of debarment. The proposal
also offered Mr. Delaney an opportunity
to request a hearing, providing him 30
days from the date of receipt of the letter
in which to file the request, and advised
E:\FR\FM\05OCN1.SGM
05OCN1
61004
Federal Register / Vol. 77, No. 194 / Friday, October 5, 2012 / Notices
him that failure to request a hearing
constituted a waiver of the opportunity
for a hearing and of any contentions
concerning this action. Mr. Delaney
failed to respond within the timeframe
prescribed by regulation and has,
therefore, waived his opportunity for a
hearing and waived any contentions
concerning his debarment (21 CFR part
12).
N–0405 and sent to the Division of
Dockets Management (see ADDRESSES).
All such submissions are to be filed in
four copies. The public availability of
information in these submissions is
governed by 21 CFR 10.20(j).
Publicly available submissions may
be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
II. Findings and Order
Dated: September 21, 2012.
Armando Zamora,
Acting Director, Office of Enforcement, Office
of Regulatory Affairs.
Therefore, the Director, Office of
Enforcement, Office of Regulatory
Affairs, under section 306(b)(1)(C) of the
FD&C Act, and under authority
delegated to the Director (Staff Manual
Guide 1410.35), finds that Mr. Stephen
C. Delaney, Jr. has been convicted of a
felony under Federal law for conduct
relating to the importation of an article
of food into the United States and that
he is subject to a 5-year period of
debarment.
As a result of the foregoing finding,
Mr. Delaney is debarred for a period of
5 years from importing articles of food
or offering such articles for import into
the United States, effective (see DATES).
Pursuant to section 301(cc) of the FD&C
Act (21 U.S.C. 331(cc)), the importing or
offering for import into the United
States of an article of food by, with the
assistance of, or at the direction of Mr.
Delaney is a prohibited act.
Any application by Mr. Delaney for
termination of debarment under section
306(d)(1) of the FD&C Act should be
identified with Docket No. FDA–2012–
[FR Doc. 2012–24528 Filed 10–4–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Request for Nominations for Voting
Members on Public Advisory
Committees
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting
nominations for voting members to
serve on the Allergenic Products
Advisory Committee, Blood Products
Advisory Committee, Cellular, Tissue
and Gene Therapies Advisory
SUMMARY:
Committee, and Transmissible
Spongiform and Encephalopathies
Advisory Committee, Center for
Biologics Evaluation and Research.
Nominations will be accepted for
vacancies that will or may occur
through December 31, 2013.
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
committees and, therefore encourages
nominations of appropriately qualified
candidates from these groups.
DATES: Because scheduled vacancies
occur on various dates throughout each
year, no cutoff date is established for the
receipt of nominations. However, when
possible, nominations should be
received at least 6 months before the
date of scheduled vacancies for each
year, as indicated in this notice.
ADDRESSES: All nominations for
membership should be sent
electronically to cv@oc.fda.gov, or by
mail to Advisory Committee Oversight
and Management Staff, 10903 New
Hampshire Ave., Bldg. 32, rm. 5103,
Silver Spring, MD 20993–0002.
Information about becoming a member
on a FDA advisory committee can also
be obtained by visiting FDA’s Web site
at https://www.fda.gov/
AdvisoryCommittees/default.htm.
FOR FURTHER INFORMATION CONTACT: For
specific Committee questions, contact
the following persons listed in Table 1
of this document:
TABLE 1
Contact person
Committee
Donald Jehn, Center for Biologics Evaluation and Research, Food and Drug Administration,
1401 Rockville Pike, HFM–71, Rockville, MD 20852, 301–827–1293; email: donald.jehn@fda.hhs.gov.
Bryan Emery, Center for Biologics Evaluation and Research, Food and Drug Administration,
1401 Rockville Pike, HFM–71, Rockville, MD 20852, 301–827–1277, email:
bryan.emery@fda.hhs.gov.
Gail Dapolito, Center for Biologics Evaluation and Research, Food and Drug Administration,
1401 Rockville Pike, HFM–71, Rockville, MD 20852, 301–827–1289, email:
gail.dapolito@fda.hhs.gov.
Allergenic Products Advisory Committee.
Blood Products Advisory Committee and
Transmissible Spongiform Encephalopathies
Advisory Committee.
Cellular, Tissue and Gene Therapies Advisory
Committee.
I. Vacancies
FDA is requesting nominations of
voting members for vacancies listed as
follows:
SUPPLEMENTARY INFORMATION:
pmangrum on DSK3VPTVN1PROD with NOTICES
TABLE 2
Upcoming vacancies
Committee expertise needed
Approximate date
needed
3
4
September 1, 2013.
October 1, 2013.
2
April 2, 2013.
Allergenic Products Advisory Committee—individuals knowledgeable in clinical immunology/allergy ......
Blood Products Advisory Committee—individuals knowledgeable in surgery/trauma, pediatric hematology/oncology, hematology, medical epidemiology.
Cellular, Tissue and Gene Therapies Advisory Committee—individuals knowledgeable in tissue engineering/regenerative medicine, orthopedic oncology.
VerDate Mar<15>2010
15:25 Oct 04, 2012
Jkt 229001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
E:\FR\FM\05OCN1.SGM
05OCN1
Agencies
[Federal Register Volume 77, Number 194 (Friday, October 5, 2012)]
[Notices]
[Pages 61003-61004]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-24528]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0405]
Stephen C. Delaney, Jr.: Debarment Order
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is issuing an order
under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) debarring
Stephen C. Delaney, Jr. for a period of 5 years from importing articles
of food or offering such articles for importation into the United
States. FDA bases this order on a finding that Mr. Delaney was
convicted of one felony count under Federal law for conduct relating to
the importation into the United States of an article of food. Mr.
Delaney was given notice of the proposed debarment and an opportunity
to request a hearing within the timeframe prescribed by regulation. As
of August 10, 2012 (30 days after receipt of the notice), Mr. Delaney
had not responded. Mr. Delaney's failure to respond constitutes a
waiver of his right to a hearing concerning this action.
DATES: This order is effective October 5, 2012.
ADDRESSES: Submit applications for termination of debarment to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kenny Shade, Office of Regulatory
Affairs, Food and Drug Administration, 12420 Parklawn Dr., Rockville,
MD 20857, 301-796-4640.
SUPPLEMENTARY INFORMATION:
I. Background
Section 306(b)(1)(C) of the FD&C Act (21 U.S.C. 335a(b)(1)(C))
permits FDA to debar an individual from importing an article of food or
offering such an article for import into the United States if FDA
finds, as required by section 306(b)(3)(A) of the FD&C Act (21 U.S.C.
335a(b)(3)(A)), that the individual has been convicted of a felony for
conduct relating to the importation into the United States of any food.
On April 8, 2011, Mr. Delaney was convicted in the U.S. District
Court for the District of Massachusetts of one count of false labeling
under the Lacey Act in violation of 16 U.S.C. 3372(d).
FDA's finding that debarment is appropriate is based on the felony
conviction referenced herein for conduct relating to the importation
into the United States of any food. The factual basis for this
conviction is as follows: As alleged in the indictment that was filed
against Mr. Delaney, he was the president and owner of a seafood
packing and re-packing company. On or about April 15, 2009, in
violation of 16 U.S.C. 3372(d), he knowingly made and submitted a false
record, account and label for, and a false identification of fish that
had been and was intended to be, imported, purchased, and received from
a foreign country and transported in interstate commerce, and involved
the sale and purchase, the offer of sale and purchase, and the intent
to sell and purchase, fish with a market value of approximately $8,000.
Specifically, Mr. Delaney falsely labeled imported frozen fillets of
pollock, product of China, as cod loins, product of Canada.
As a result of his conviction, on July 9, 2012, FDA sent Mr.
Delaney a notice by certified mail proposing to debar him for a period
of 5 years from importing articles of food or offering such articles
for import into the United States. The proposal was based on a finding
under section 306(b)(1)(C) of the FD&C Act that Mr. Delaney was
convicted of a felony under Federal law for conduct relating to the
importation into the United States of an article of food because he
knowingly made and submitted a false record, account and label for, and
a false identification of fish that had been and was intended to be,
imported, purchased, and received from a foreign country and
transported in interstate commerce, and involved the sale and purchase,
the offer of sale and purchase, and intent to sell and purchase, fish
with a market value of approximately $8,000.
The proposal was also based on a determination, after consideration
of the factors set forth in section 306(c)(3) of the FD&C Act (21
U.S.C. 335a(c)(3)), that Mr. Delaney should be subject to a 5-year
period of debarment. The proposal also offered Mr. Delaney an
opportunity to request a hearing, providing him 30 days from the date
of receipt of the letter in which to file the request, and advised
[[Page 61004]]
him that failure to request a hearing constituted a waiver of the
opportunity for a hearing and of any contentions concerning this
action. Mr. Delaney failed to respond within the timeframe prescribed
by regulation and has, therefore, waived his opportunity for a hearing
and waived any contentions concerning his debarment (21 CFR part 12).
II. Findings and Order
Therefore, the Director, Office of Enforcement, Office of
Regulatory Affairs, under section 306(b)(1)(C) of the FD&C Act, and
under authority delegated to the Director (Staff Manual Guide 1410.35),
finds that Mr. Stephen C. Delaney, Jr. has been convicted of a felony
under Federal law for conduct relating to the importation of an article
of food into the United States and that he is subject to a 5-year
period of debarment.
As a result of the foregoing finding, Mr. Delaney is debarred for a
period of 5 years from importing articles of food or offering such
articles for import into the United States, effective (see DATES).
Pursuant to section 301(cc) of the FD&C Act (21 U.S.C. 331(cc)), the
importing or offering for import into the United States of an article
of food by, with the assistance of, or at the direction of Mr. Delaney
is a prohibited act.
Any application by Mr. Delaney for termination of debarment under
section 306(d)(1) of the FD&C Act should be identified with Docket No.
FDA-2012-N-0405 and sent to the Division of Dockets Management (see
ADDRESSES). All such submissions are to be filed in four copies. The
public availability of information in these submissions is governed by
21 CFR 10.20(j).
Publicly available submissions may be seen in the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
Dated: September 21, 2012.
Armando Zamora,
Acting Director, Office of Enforcement, Office of Regulatory Affairs.
[FR Doc. 2012-24528 Filed 10-4-12; 8:45 am]
BILLING CODE 4160-01-P